Back to Events
Webinar

How to Navigate the Changing Competitive Landscape: Partnership Strategies for Orthopaedic Group Executives

Wednesday, January 22, 2025
12:00 PM - 12:30 PM (CST)

Join Us Virtually

Event Details

How to Navigate the Changing Competitive Landscape: Partnership Strategies for Orthopaedic Group Executive

January 22nd, 2025; 12:30 p.m. - 1:00 p.m. EST

Cost:
Members - Free
Nonmembers - $50
You must be logged in as an active member to receive the discounted ticket price

 

Strategic partnerships for orthopaedic groups continue to evolve -- including joint ventures, mergers and acquisitions, and major affiliations. Future growth in these transactions is expected during 2025 and beyond as orthopaedic groups strive to improve operational efficiency, enhance patient care, and leverage economies of scale -- all in the face of various challenges, including increasing costs, decreasing reimbursement, and enhanced local competition.

Private equity platforms, national healthcare companies, and large healthcare systems continue to pursue partnerships with orthopaedic practices and orthopaedic group executives in order to capitalize on rising demand for outpatient services and value-based care models.

Moving into 2025, amid these ongoing consolidation trends, orthopaedic executives will need to carefully navigate how best to improve and/or maintain physician compensation levels, and address integration challenges and regulatory compliance -- all while preserving clinical autonomy.

 

Register Now!

 

Learning objectives:
  • The last trends in strategic partnerships for orthopaedic groups. 
  • How to best position an orthopaedic group to maximize its value and autonomy in partnership transactions.
  • The role of orthopaedic group executives before, during and after a strategic transaction. The potential benefits of a strategic partnership for orthopaedic surgeons and group executives.
  • Pitfalls for executives and surgeons to avoid in connection with exploring and effectuating a partnership transaction.

 

 

Sponsored by:

For more information - contact Jessica Thornburg at jthornburg@aaoe.net 

  

Due to AAOE policies, AI Bots are not allowed in webinars, and AAOE staff will remove them. 

Speakers:

 

  

Gary Herschman
Chair, Healthcare Transactions Group - Epstein Becker & Green

"Gary Herschman is a healthcare M&A (transactions) attorney and partner at Epstein, Becker & Green.  Gary has been advising healthcare providers and related businesses on mergers, acquisitions, joint ventures, and other strategic transactions for over 30 years, and is known throughout the country as a top leader in healthcare consolidation deals and ventures.

Gary is nationally recognized as more than just a great deal attorney, but also as a healthcare industry thought leader, educator and strategist. 

Gary writes articles and is quoted on this topic in many national healthcare publications including:  Becker's, Modern Healthcare, Medical Economics, MergerMarket, Irving Levin, Orthopedics Today, Healio, MGMA, Crain's, Bloomberg, Journal of Orthopaedic Experience & Innovation, Part B News, and Kaiser Health News.  

He also and frequently speaks at national healthcare industry conferences including, multiple presentations at annual meetings of:  AAOS, AAHKS, AAOE, ICJR, IOEN, Ortho Summit, MGMA, Becker's ASC, Becker's Spine, OEIS, and MedAxiom."

 

 

  

Dana Jacoby
Chief Executive Officer - Vector Medical Group

"Dana Jacoby is recognized as a difference maker and trusted advisor to health system executives, medical practices, vendors, and other stakeholders in optimizing patient care while also elevating financial and operational performance. 
Dana’s passion for operational excellence has driven a distinguished record of achievement at the intersection of market data, measurement and analytics, strategy design and implementation, and technology innovation.  

She is a published author and engages audiences as a keynote speaker, educator, and subject matter expert at medical forums, summits, and conferences. Dana has played a pivotal role in leading transformation throughout the highly regulated and value-centric health care industry.

Dana also has advised dozens of orthopaedic groups across the country over the last 10 years on the business, financial and strategic aspects of partnership and affiliation transactions."